Open menu
Paytm Money logo
Reliance Mutual Fund

Reliance Pharma Fund Direct-Dividend Reinvestment

NAV
returns change indicator
61.4185
as on 20 Sep 2019 09:45 PM
1.6471(2.76%)
Last Change
loaderloader
Investment Performance
would have given a returns of
110,871
star
121,647
star
98,379
star
100,977
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
978
Profit (absolute return)
0.98%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
2.86%
In the last 6 months
4.22%
In the last 1 year
10.99%
In the last 3 years
0.98%
In the last 5 years
26.52%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
Reliance Pharma Fund Direct-Dividend Reinvestment
Reliance Pharma Fund Direct-Dividend Reinvestment
as of 20 Sep 2019 09:45 PM
2,377.03 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year
1.36%
Expense Ratio
Plan
Dividend
0.56%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year
Scheme Document
Sectors Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Healthcare
99.38%
2,362.29 Cr
Cash Holding
0.56%
13.31 Cr
Sectors Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Healthcare
99.38%
2,362.29 Cr
Cash Holding
0.56%
13.31 Cr
Companies Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
12.32%
292.85 Cr
Divi's Laboratories Ltd.
10.26%
243.88 Cr
Cipla Ltd.
8.55%
203.24 Cr
Aurobindo Pharma Ltd.
8.34%
198.24 Cr
Lupin Ltd.
7.17%
170.43 Cr
Dr. Reddy's Laboratories Ltd.
6.99%
166.15 Cr
Abbott India Ltd.
6.75%
160.45 Cr
Syngene International Ltd.
6.53%
155.22 Cr
Fortis Healthcare (India) Ltd
5.95%
141.43 Cr
Sanofi India Ltd.
5.82%
138.34 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
12.32%
292.85 Cr
Divi's Laboratories Ltd.
10.26%
243.88 Cr
Cipla Ltd.
8.55%
203.24 Cr
Aurobindo Pharma Ltd.
8.34%
198.24 Cr
Lupin Ltd.
7.17%
170.43 Cr
Dr. Reddy's Laboratories Ltd.
6.99%
166.15 Cr
Abbott India Ltd.
6.75%
160.45 Cr
Syngene International Ltd.
6.53%
155.22 Cr
Fortis Healthcare (India) Ltd
5.95%
141.43 Cr
Sanofi India Ltd.
5.82%
138.34 Cr
View All
View All
About Reliance Pharma Fund Direct-Dividend Reinvestment
Reliance Pharma Fund Direct-Dividend Reinvestment is a Equity mutual fund scheme from Reliance Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹2,377.03 Crores and the latest NAV decalared is ₹61.419 as on 20 Sep 2019 at 9:45 pm.
Reliance Pharma Fund Direct-Dividend Reinvestment scheme return performance in last 1 year is -10.99%, in last 3 years is 0.98% and 118.44% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
AUM:2,377.03 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.
AMC Information
Reliance Mutual Fund
Reliance Mutual Fund
View AMC Details
195,751.84 Cr
AUM
185
Schemes
Address
Address
Reliance Centre, 7th Floor, South WingOff Western Express HighwaySantacruz (East)400055
Phone Number
Phone Number
Phone : 022-68334800 / 18602660111
Fax : 022-33037662